Merck Enflonsia wins ACIP backing for RSV protection in infants under 8 months Ruchika Sharma29 Jun 2025 1:15 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Centers for Disease Control and Prevention (CDC)...
Phase 3 trial initiated for Ifinatamab Deruxtecan in Pretreated Metastatic Castration-Resistant Prostate Cancer: Merck, Daiichi Sankyo Ruchika Sharma19 Jun 2025 10:00 AM ISTBasking Ridge: Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating...
Merck begins Phase 3 study for Dengue vaccine candidate Ruchika Sharma13 Jun 2025 11:00 AM ISTMerck is establishing a program of clinical trials for V181, including conducting trials globally, in places where dengue is a significant health...
Merck RSV antibody Enflonsia gets USFDA okay for infants Ruchika Sharma10 Jun 2025 11:06 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA)...
Merck posts positive phase 3 trials results evaluating Enlicitide Decanoate in adults with Hyperlipidemia Ruchika Sharma10 Jun 2025 9:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the first two of three...
Merck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma Ruchika Sharma15 May 2025 11:45 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug Administration...
Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion Ruchika Sharma27 April 2025 4:00 PM ISTBengaluru: Merck KGaA, a science and technology company, is in late-stage negotiations to buy SpringWorks Therapeutics, a US based...
Merck Capvaxive gets European Commission nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults Ruchika Sharma27 March 2025 12:15 PM ISTEuropean Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and...
Merck gets rights to develop, commercialize Jiangsu Hengrui Pharma heart drug worldwide, excluding Greater China region Ruchika Sharma25 March 2025 5:22 PM ISTThe transaction is expected to close in the second quarter of 2025.
Merck injected version of Keytruda faces possible patent challenge: Report Ruchika Sharma6 March 2025 5:06 PM ISTMerck's newly developed injected version of its blockbuster cancer drug, Keytruda, may be at the center of a potential patent dispute,...
Merck to increase workforce at Indian sites by year end Ruchika Sharma1 March 2025 3:54 PM ISTDrug Maker Merck expects to boost employment in India with increment in its workforce across its India sites by the end of the year, a senior...
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma Ruchika Sharma27 Feb 2025 3:17 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
